Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Platelet-vessel wall interaction: from the bedside to molecules

J P Caen1, J P Rosa

  • 1Institut des Vaisseaux et du Sang, Hôpital Lariboisière, Paris, France.

Thrombosis and Haemostasis
|July 1, 1995
PubMed
Summary

This review traces 75 years of progress in platelet-vessel wall interactions, from early disorder descriptions to molecular biology insights. Future antithrombotic therapies targeting key platelet glycoproteins are emerging.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Elastase-Like Enzyme of Platelets.

Thrombosis and haemostasis·2019
Same author

Impact of electronic-cigarette refill liquid on rat testis.

Toxicology mechanisms and methods·2016
Same author

Experimental photophysical characterization of fluorophores in the vicinity of gold nanoparticles.

Nanotechnology·2011
Same author

The Anti-aggregating Peptide KRDS Impairs a-granule Release, Whereas RGDS Does Not.

Platelets·2010
Same author

Abrupt oxygen decrease influences thrombosis and bleeding in stenosed and endothelium-injured rabbit carotid arteries.

European journal of anaesthesiology·2008
Same author

1-Deamino (8-D-arginine) vasopressin infusion partially corrects platelet deposition on subendothelium in Bernard-Soulier syndrome: the role of factor VIII.

Platelets·2006

Area of Science:

  • Hematology
  • Vascular Biology
  • Molecular Medicine

Background:

  • Historical overview of platelet-vessel wall interaction research spanning 75 years.
  • Chronological progression through distinct eras: Prehistoric (1918-1948), Physiopathological (1957-1972), Glycoprotein (1974-1981), and Molecular Biology (1984-1995).
  • Focus on understanding inherited platelet disorders like Glanzmann thrombasthenia, von Willebrand disease, and Bernard Soulier syndrome.

Observation:

  • Early research identified specific platelet adhesion and aggregation abnormalities in inherited disorders.
  • Discovery of defects in glycoproteins GPIIb-IIIa and GPIb-IX in Glanzmann thrombasthenia and Bernard Soulier syndrome, respectively.
  • Molecular biology advancements led to the cloning of genes responsible for these platelet disorders.

Findings:

Related Experiment Videos

  • Platelet adhesion defects are noted in von Willebrand disease and Bernard Soulier syndrome.
  • Platelet aggregation defects are characteristic of thrombasthenias.
  • Identification of specific glycoprotein defects (GPIIb-IIIa, GPIb-IX) has been crucial for understanding platelet function.

Implications:

  • Understanding platelet-vessel wall interactions is key to diagnosing and treating bleeding disorders.
  • The molecular basis of these disorders has been elucidated through gene cloning.
  • Emerging antithrombotic therapies target critical platelet glycoprotein complexes, such as GPIb-vWF and GPIIb-IIIa.